Side effects People respond to medications in different ways, and even though Mounjaro and Wegovy share similar ingredients, you may tolerate one better than the other
For patients with obesity who also have fatty liver disease, it offers real hope that we can slow down or stop the progression to cirrhosis. Expanding MASH treatment options The expanded approval for Wegovy could be good news for a growing number of people with severe liver disease
My C-reactive levels have been well over 1.5 for five years until starting the microdose." David Kellner, MD: I would say a decrease in CRP, or C-reactive protein, is encouraging
Phase 3 trials extended to 68 weeks confirmed continued weight loss (28.7% at 68 weeks vs 24.2% at 48 weeks on the 12mg dose)
Regular application reduces wrinkles, smooths fine lines, enhances skin texture, and restores radiance, leaving your skin healthier, firmer, and noticeably more youthful under the expert guidance of NEXTDRIP professionals